Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy

Clinical trial NCT00888082 · WITHDRAWN

Trial details

NCT number: NCT00888082
Sponsor: AstraZeneca
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Ovarian Function

Primary completion: 2012-04-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.